anetumab,bevacizumab
bayer,roche
['anetumab', 'bevacizumab', 'ovarian', 'gyn']
 #etctn (10150) #gynecologicalcancer initial results coming up at #asco22! a randomized phase 2 study of bevacizumab and either weekly anetumab ravtansine or weekly paclitaxel in platinum-resistant or platinum refractory ovarian cancer . 
Official Twitter account of the NCI Cancer Therapy Evaluation Program, providing updates to our trials research community. Privacy: https://t.co/47s9FxzVVe.